NHLBI Type II Coronary Intervention Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1971
To determine whether lowering of cholesterol with cholestyramine in a population with Type II hyperlipidemia led to a decreased rate of progression (a regression of coronary artery disease) as demonstrated by death, myocardial infarction, or progression of disease on angiography.
Epistemonikos ID: 8d90ab0a93ece495d7d39d798a33c303417cffe0
First added on: May 03, 2024